2026 · 3rd Quarter (July 1 - Sep 30)

ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)

Filed by FIERCE GOVERNMENT RELATIONS.

Open official filing

Source-reported fields

Filing overview

Type: 3rd Quarter - Report
Posted: Oct 20, 2026
Income: $60,000.00
Expenses: Not reported
Registrant: FIERCE GOVERNMENT RELATIONS
Client: ASSOCIATION OF ACCESSIBLE MEDICINES (FORMERLY KNOWN AS GPHA)
Filing UUID: e0aecdb2-0389-43fd-8b57-807a47fd3efa
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

PHA · Pharmacy

Biosimilars; Generic drugs; Issues around country of origin labeling; Supply Chain; S.2658 - Medication Affordability and Patent Integrity Act; S.3014 - Ensuring Timely Access to Generics Act; S.1414 - Expedited Access to Biosimilars Act; S.1954 - Biosimilar Red Tape Reduction Act; S.3788 - Clear Labels Act; S.43 - Skinny Labels, Big Savings Act; Tariffs; General Business Issues.

Literal federal measure citations: S.2658, S.3014, S.1414, S.1954, S.3788, S.43

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.